Montelukast Prescribing at MANSION HOUSE
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
2,026
Total Quantity
59.5K
NHS Cost
£3.1K
vs National Avg
+195.9%
MANSION HOUSE prescribed 2,026 items of Montelukast over the last 12 months at a cost of £3,136 to the NHS. This is 195.9% above the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jul 2026
167
Jul 2026
161
Jul 2026
189
Jul 2026
169
Jul 2026
161
Jul 2026
170
Jul 2026
168
Jul 2026
168
Jul 2026
191
Jul 2026
143
Jul 2026
170
Jul 2026
169
Prescribing Details
| Total Items | 2,026 |
|---|---|
| Total Quantity | 59,512 |
| Total NHS Cost | £3,136 |
| Presentations | 4 different forms |
| vs National Average | +195.9% |
Montelukast Prescribing Comparison
| This practice | 2,026 items |
|---|---|
| National average per practice | 685 items |
| Difference | +195.9% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.